Coping strategies and patient-reported outcomes (PROs) in early-phase cancer clinical trial (EP-CT) participants

被引：0
|
作者：
Lundquist, Debra
Lam, Anh B.
Pelletier, Andrea
Durbin, Sienna
Petrillo, Laura A.
Jimenez, Rachel
Turbini, Victoria
Bame, Viola
Lynch, Kaitlyn
Yalala, Vaishnavi Reddy
Ollila, Nicholas
Malowitz, Benjamin
McIntyre, Casandra
Juric, Dejan
Nipp, Ryan David
机构：
[1] Massachusetts Gen Hosp, Henri & Belinda Termeer Ctr Targeted Therapies, Boston, MA USA
[2] Univ Oklahoma, Hlth Sci Ctr, Oklahoma City, OK USA
[3] Brigham & Womens Hosp, Boston, MA USA
[4] Massachusetts Gen Hosp, Boston, MA USA
[5] Univ Oklahoma, Oklahoma City, OK USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e23194
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Coping strategies, trajectories, and their associations with patient-reported outcomes among women with ovarian cancer
    Vanessa L. Beesley
    David D. Smith
    Christina M. Nagle
    Michael Friedlander
    Peter Grant
    Anna DeFazio
    Penelope M. Webb
    Supportive Care in Cancer, 2018, 26 : 4133 - 4142
  • [32] Coping strategies, trajectories, and their associations with patient-reported outcomes among women with ovarian cancer
    Beesley, Vanessa L.
    Smith, David D.
    Nagle, Christina M.
    Friedlander, Michael
    Grant, Peter
    DeFazio, Anna
    Webb, Penelope M.
    SUPPORTIVE CARE IN CANCER, 2018, 26 (12) : 4133 - 4142
  • [33] THE EMERGING ROLE OF PATIENT-REPORTED OUTCOMES (PROS) IN CLINICAL TRIALS IN INDIA
    Bn, V
    Naidu, M.
    Esam, H.
    Badgujar, L.
    Kinra, G.
    Dang, A.
    VALUE IN HEALTH, 2015, 18 (03) : A102 - A102
  • [34] Evaluating linguistic equivalence of patient-reported outcomes in a cancer clinical trial
    Hahn, Elizabeth A.
    Bode, Rita K.
    Du, Hongyan
    Cella, David
    CLINICAL TRIALS, 2006, 3 (03) : 280 - 290
  • [35] Patient-Reported Outcomes (PROs) in COPD Clinical Trials: Trends and Gaps
    Afroz, Nuzhat
    Gutzwiller, Florian S.
    Mackay, Alex J.
    Naujoks, Christel
    Patalano, Francesco
    Kostikas, Konstantinos
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2020, 15 : 1789 - 1800
  • [36] Relevance of patient-reported outcomes (PROs) in patients with cancer at advanced age
    Stauder, R.
    Stojkov, I.
    Rochau, U.
    Conrads-Frank, A.
    Siebert, U.
    Koinig, K.
    ONCOLOGY RESEARCH AND TREATMENT, 2019, 42 : 32 - 32
  • [37] Prognostic value of patient-reported outcomes (PROs) in advanced cancer.
    Patel, Shiven B.
    Akerley, Wallace L.
    Ose, Dominik
    Haydell, Tyler
    Martineau, Jim
    Dunson, William A.
    Chalmers, Anna Weinberg
    Cannon, Laura
    Meropol, Neal J.
    Haaland, Ben
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (30)
  • [38] The use of patient-reported outcomes (PROs) in cancer care: a realistic strategy
    Minvielle, E.
    di Palma, M.
    Mir, O.
    Scotte, F.
    ANNALS OF ONCOLOGY, 2022, 33 (04) : 357 - 359
  • [39] Guidance on the inclusion of Patient-Reported Outcomes (PROs) in clinical trial protocols: the SPIRIT-PRO extension
    Calvert, Melanie J.
    Kyte, Derek G.
    Mercieca-Bebber, Rebecca
    Slade, Anita
    Chan, An-Wen
    King, Madeleine T.
    QUALITY OF LIFE RESEARCH, 2017, 26 (01) : 38 - 38
  • [40] EARLY ONSET OF BENEFIT BY PATIENT-REPORTED OUTCOMES (PROS) WITH SARILUMAB TREATMENT IN RA
    Strand, V.
    Chen, C.
    Mahajan, P.
    Kosinski, M.
    Mangan, E. K.
    van Hoogstraten, H.
    Graham, N.
    Lin, Y.
    Keystone, E.
    Braun, J.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 984 - 985
12345